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Abstract
CONTEXT: The phenotype of 45,X/46,XY mosaicism is heterogeneous ranging
from females with Turner syndrome (TS) to apparently normal males. Males
with 45,X/46,XY frequently show stigmata typically associated with TS. We
hypothesised that males with 45,X/46,XY have similar cardiovascular pathology
as females with 45,X/46,XY. OBJECTIVE: To investigate cardiovascular
abnormalities in 45,X/46,XY males and to compare them with 45,X/46,XY
females. DESIGN: Patients with 45,X/46,XY mosaicism were selected from
the Belgian Registry for Growth and Puberty problems and via the
multidisciplinary clinic for disorders of sexual development. PATIENTS:
EIGHTEEN PATIENTS WERE INCLUDED: 8 raised as females (F) and 10
as males (M). INTERVENTION: Complete cardiac examination with blood
pressure measurement, ECG, echocardiography and MRI. MAIN OUTCOME
MEASUREMENT: Cardiac parameters were registered for both groups. In a
second phase, clinical features and external masculinisation score (EMS) were
retrospe...
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Abstract
Context: The phenotype of 45,X/46,XY mosaicism is heterogeneous ranging from females with Turner syndrome (TS) to
apparently normal males. Males with 45,X/46,XY frequently show stigmata typically associated with TS. We hypothesised
that males with 45,X/46,XY have similar cardiovascular pathology as females with 45,X/46,XY.
Objective: To investigate cardiovascular abnormalities in 45,X/46,XY males and to compare them with 45,X/46,XY females.
Design: Patients with 45,X/46,XY mosaicism were selected from the Belgian Registry for Growth and Puberty problems and
via the multidisciplinary clinic for disorders of sexual development.
Patients: Eighteen patients were included: 8 raised as females (F) and 10 as males (M).
Intervention: Complete cardiac examination with blood pressure measurement, ECG, echocardiography and MRI.
Main Outcome Measurement: Cardiac parameters were registered for both groups. In a second phase, clinical features and
external masculinisation score (EMS) were retrospectively collected from the medical files.
Results: A structural heart defect was diagnosed before inclusion in 1 F with coarctation and 1 M with spontaneously closed
VSD. A bicuspid aortic valve was found in 8 (3 F, 5 M). Dilation of the ascending aorta was present in 4 M and was severe in
2 young boys. QTc was prolonged in 3 F and 2 M.
Conclusion: Males with 45,X/46,XY mosaicism have similar cardiovascular pathology as 45,X/46,XY females. Dilation of the
ascending aorta can be important, also in males. We advise cardiac screening and life-long monitoring in all males with
45,X/46,XY mosaicism according to the existing guidelines for Turner syndrome.
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Introduction
Turner syndrome (TS) is a genetic disorder, occurring in
approximately 50 per 100 000 live born girls [1]. Monosomy X is
present in about 50% of the cases. The remaining have a mosaic
karyotype, consisting of a 45,X cell line in combination with at
least one of the following : 46,XX (or variants), 47,XXX (or
variants), or a whole or partial Y chromosome [1,2]. Cardinal
features of TS include reduced final height and gonadal failure.
Diabetes, hypothyroidism, hearing disorders, scoliosis, renal
abnormalities and neurocognitive disorders are frequently associ-
ated pathologies [3]. Compared to the normal population,
morbidity and mortality are high, circulatory disease accounting
for the greatest excess mortality [4–6]. Structural heart defects are
found in one fourth to half of the Turner patients and involve
mainly the left side of the heart. Bicuspid aortic valve, coarctation
aortae and dilation of the ascending aorta are the most common
[3,7–9]. Hypertension occurs in about half of the patients [10,11].
Current guidelines advocate systematic and repeated cardiac
screening in all Turner patients [12].
In about 6% of TS girls, 45,X/46,XY mosaicism is documented
[13]. On the other hand, sex chromosome mosaicism (45,X/
46,XY and variants) is sometimes diagnosed in apparently normal
males presenting at infertility clinics, in boys consulting for short
stature or in neonates born with genital ambiguity [14,15]. Some
PLOS ONE | www.plosone.org 1 February 2013 | Volume 8 | Issue 2 | e54977
male patients show stigmata typically associated with TS, e.g. short
stature, renal pathology and coarctation [15]. To our knowledge,
no data exist on the frequency and nature of cardiovascular
pathology in males with 45,X/46,XY.
The present study was undertaken to investigate cardiovascular
abnormalities in 45,X/46,XY males and to compare them with
45,X/46,XY girls with TS. In view of the description of some
(fatal) cases of aortic dilation in males with 45,X/46,XY mixed
gonadal dysgenesis [16], this information is highly relevant, taking
into account that current guidelines on regular cardiac follow-up
exclusively implicate girls with TS. If similar cardiovascular
pathology is encountered in 45,X/46,XY boys and girls alike,
consequent adjustment of these guidelines is mandatory.
Patients and Methods
Study Population
We identified patients with 45,X/46,XY mosaicism from the
Belgian Registry for Growth and Puberty problems. Four Belgian
university centres agreed to let their patients take part in a single-
centre cardiovascular study. The study protocol was approved by
the ethical committee of Ghent University Hospital and addition-
ally by the ethical committee of each participating centre. From
the 34 identified patients, 11 accepted to participate in the study
protocol. Seven additional patients were included via the
multidisciplinary clinic for disorders of sexual development of
the Ghent University Hospital. All patients and/or their parents
gave written informed consent.
All investigations were performed in one day at Ghent
University Hospital from May 2009 to November 2011. Clinical
cardiac examination was performed by one experienced paediatric
cardiologist (KDG). Height and weight were measured and used to
calculate body surface aera (BSA) according to the Haycock’s
formula [17].
Blood pressure was taken at the 4 limbs, with the patient at rest
and in a supine position (Datascope, Accutorr Plus, USA). In
children and adolescents, blood pressure was considered border-
line if $p95 and high if $p97 for age and height [18]. In adults,
hypertension was defined as a systolic pressure $130 mmHg and/
or a diastolic pressure $85 mm Hg.
A standard 12 leads ECG (GE Healthcare, Marquette
Mac5000, USA) was recorded and analysed by one single observer
(KDG). Conform the international guidelines, QTc was manually
calculated in at least 3 consecutive heartbeats, based on Bazett’s
formula. QTc was considered prolonged if .450 ms [19].
Echocardiography was performed by a single observer (KDG)
with the use of a VIVID 7 ultrasound (GE Vingmed Ultrasound,
Horten, Norway) equipped with a 3,5 MHz and 7 MHz probe.
Evaluation included a complete study with 2D, M-mode and
Doppler. Data were stored and used for offline analysis using
EchoPAC version 110.1.0 software (GE Vingmed Ultrasound).
Diameters of the aorta were measured from the parasternal long
axis in systole from inner tot inner surface at the level of the aortic
valve annulus, aortic root (AoRt), sinotubular junction (STJ) and
ascending aorta (AoAsc). Measurement of the transverse arch was
obtained from the suprasternal notch. Measurement of the
interventricular septum, posterior wall and internal diameters
were performed on a parasternal short axis and used for
calculation of fractional shortening. For each variable, z-scores
were calculated [20].
Cardiac MRI was performed on a 1.5T magnet (slope 45 mt/
m, slewrate: 200T/m/sec) (Siemens Avanto, Erlangen) and
analysed by one single observer (DD). ECG gated TrueFISP cine
imaging of cardiac long axis and the left ventricle outflow
apparatus were acquired. A 3D flash sequence was used before
and during intravenous injection of Gadobutol (Bayer Schering) at
1 ml/10 kg bodyweight, using a bolus tracking technique for
optimal timing of the acquisition of arterial phase images.
Evaluation of aortic valve was done on the cine images.
Assessment of the thoracic aorta consisted of multiplanar
reconstruction perpendicular to the aortic lumen, and measure-
ment of the aortic diameters: aortic valve annulus, AoRt, STJ and
AoAsc. The diameter of the ascending aorta was divided by BSA
to correct for the relative short stature of the patients. An
ascending aorta/BSA (indexed AoAsc).20 mm/m2 was consid-
ered dilated, $25 mm/m2 severely dilated [21].
Clinical data were collected from the medical records. The
genital phenotype of the patients at first examination, if other
than typically female, was described by the external masculini-
sation score (EMS) which represents a clinical scoring system
(based on the position of the gonads, length of the phallus,
presence of labioscrotal fusion and position of the urethreal
meatus) to quantitatively assess the degree of undervirilisation
[22].
Results
Patients
Eighteen patients were included in the study, of which 8 (age
13–31 y, median 19 y) were raised as females (further referred to
as females/F) and 10 (age 0–24, median 9,5 y) as males (further
referred to as males/M). Seven females had typical TS features
with typical female external genitalia and short stature. Addition-
ally, one child with ambiguous genitalia at birth was raised female.
Four males were born with typical male external genitalia (EMS
12/12). Four showed milder (EMS 8–10/12) and 2 severe (EMS
5–6/12) degrees of undervirilisation. In male patients, features
typically associated with TS, were frequently encountered. De-
tailed information on genotypes and phenotypes is represented in
Table 1 and 2.
Fourteen patients (8 F, 6 M) received growth hormone for short
stature. In four males, although short for age and (assigned) sex,
growth hormone was not started yet in view of their young age.
Clinical Examination and Cardiac History
Clinical cardiac examination was normal in all patients, except
for the girl with previous cardiac surgery and a boy of 5 years old
with a soft innocent murmur. None of them had any complaints or
symptoms suggestive of underlying cardiovascular disease.
Five patients (4 F, 1 M) had previously visited a (paediatric)
cardiologist. Routine echocardiography was performed in 3
females with TS and turned out to be normal in 2 patients,
whereas one showed a bicuspid aortic valve. Additionally, one
girl was previously diagnosed with a BAV and underwent
neonatal cardiac surgery for coarctation of the aorta. One boy
was known from infancy with a BAV and spontaneous closure
of a VSD.
Blood Pressure
Blood pressure was slightly elevated in 3 patients (2 F, 1 M),
including the girl previously treated for coarctation.
ECG
All except one (M, 1 year old) patient received a standard 12
leads ECG. In all, heart rate was within the normal range for age
and (assigned) sex, although in 3 females and 3 males heart rate
was at the upper limit of normal. A prolonged QTc was found in 5
patients (3 F, 2 M). QTc dispersion was longer than 60 ms in 10
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patients (6 F, 4 M). No episodes of arrhythmia were reported.
None of the patients received QTc prolonging medication.
Echocardiography
Echocardiography was performed in all patients. A BAV was
found in 8 (3 F, 5 M). None of the aortic valves was insufficient
nor stenotic. Dimensions of AoRt and STJ were normal in all, but
echocardiography failed to visualise the ascending aorta in 5
patients (4 F, 1 M). All received a cardiac MRI. Mild dilation (z-
score 2.33–2.94) of the AoAsc was found in 3 patients (1 F, 2 M),
severely dilation (Z-score 4.48–6.19) of the AoAsc in 2 (2 M).
Inflow patterns over the mitral valve were normal in all patients.
Systolic function was impaired (FS 26%) in a 10 year old boy, who
also showed a severely dilated AoAsc.
Cardiac MRI
MRI was performed in 12 patients. BAV was found in 4 (3 F,
1 M); in all, BAV was correctly diagnosed on echocardiography.
Dimensions of AoRt and STJ were normal in all patients.
Indexed AoAsc was smaller than 20 mm/m2 in 11 patients (8 F,
3 M) but was 25.9 mm/m2 in the boy who showed severe dilation
on echocardiography (see Figure 1). The other boy diagnosed with
severely dilated indexed AoAsc refused to have an MRI. All
patients with dilated AoAsc had a BAV.
Table 1. Genotype and phenotype of patients with 45,X/46,XY (or variant) raised female.
Age£ Age D££ Karyotype EMS Associated features Cardiovascular
21 y 15 y 45,X/46,XY non-ambiguous F short stature bicuspid aortic valve
short, webbed neck prolonged QTc (465 ms)
shield thorax high heart rate (97/min)
cubitus valgus
recurrent otitis
hypothyroidism
30 y 9 y 45,X/46,XY non-ambiguous F short stature prolonged QTc (471 ms)
shield thorax
recurrent otitis
38 y 12 y 45,X/46,XY non-ambiguous F short stature,** normal
13 y neonatal 45,X/46,X,i(Y)(q10) non-ambiguous F short stature bicuspid aortic valve
pectus excavatus coarctation
short metacarpals
dysmorphic auricles
recurrent otitis
impaired vision
15 y 8 y 45,X/46,XY non-ambiguous F short stature dilated left art. subclavia
short, webbed neck
shield thorax
cubitus valgus
short metacarpals
short metatarsals
recurrent otitis
ADHD
13 y 10 y 45,X/46,XY non-ambiguous F short stature bicuspid aortic valve
cubitus valgus prolonged QTc (457 ms)
recurrent otitis high heart rate (92/min)
neurocognitive disorder dilated left art. subclavia
13 y 1y 45,X/46,X, mar(Yq12) non-ambiguous F short stature
dysmorphic auricles
recurrent otitis
hearing impairment
horseshoe kidney
high heart rate (82/min)
26 y neonatal 45,X/46,XY virilisation* short stature, ** right arteria lusoria
£Age at the moment of examination in years,
££Age at the moment of diagnosis.
*Clinical data are insufficient to calculate the EMS,
**more clinical data are not available.
EMS external masculinisation score.
doi:10.1371/journal.pone.0054977.t001
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No patients were diagnosed with a persistent left superior caval
vein or partial abnormal pulmonary venous return. MRI gave the
additional diagnosis of a right sided arteria lusoria in two (1 F,
1 M) and a dilated left subclavian artery in two females.
Data on cardiovascular findings are summarized in Table 1 and
2.
Discussion
Patients with 45,X/46,XY mosaicism and normal female
external genitalia are often diagnosed with TS during childhood,
due to short stature and eventually associated dysmorphic features.
These girls enter a strict medical follow-up protocol, according to
international guidelines, in order to prevent or treat an array of
associated medical conditions such as short stature, conductive
hearing loss, strabismus, celiac disease, hypothyroidism, metabolic
disturbances and diabetes [12].
Although not always recognized, 45,X/46,XY boys often
present with similar dysmorphic features, growth disturbances
and comparable health problems later in life. As in TS, growth
hormone therapy has proven to be effective in 45,X/46,XY boys
with short stature [23]. In addition, 45,X/46,XY males frequently
suffer from (mixed) gonadal dysgenesis and infertility and also
renal pathology is reported [15]. In our series of 45,X/46,XY
males, phenotypical features typically associated with TS were
frequently encountered.
Table 2. Genotype en phenotype of patients with 45,X/46,XY (or variant) raised male.
Age£ Age D££ Karyotype EMS Associated features Cardiovascular
21 y 10 y 45,X/46,X,der(Y) 12 short stature,** normal
24 y 7 y 45,X/46,X,idic(Y)(q11.21) 12 short stature bicuspid aortic valve
cubitus valgus
short metacarpals
short metatarsals
neurocognitive disorder
11 y 10 y 45,X/46,X,idic(Y)(p11.32) 12 short stature bicuspid aortic valve
short neck mildly dilated AoAsc
shield thorax prolonged QTc (465 ms)
short metacarpals high heart rate (95/min)
short metatarsals
Scoliosis
ADHD
recurrent otitis
1 y prenatal 46,X,i(Y) (pterRq11:q11Rpter) 12 cleft lip and palate normal
10 y 1 y 45,X/46,XY 10 short stature bicuspid aortic valve
short, webbed neck dilated AoAsc
shield thorax impaired systolic function
short metacarpals prolonged QTc (482 ms)
short metatarsals high heart rate (94/min)
recurrent otitis
19 y 1 y 45,X/46,XY 10 short stature,** right arteria lusoria
3 y prenatal 45,X/46,X,i(Y)(p10) 10 short stature bicuspid aortic valve
multicystic kidney mildly dilated AoAsc
recurrent otitis
10 y neonatal 45,X/46,XY 8 short stature VSD
short neck bicuspid aortic valve
shield thorax dilated AoAsc
short metacarpals high heart rate (99/min)
short metatarsals
horseshoe kidney
5 y neonatal arrYq11.223q11.223/XO 6 normal
2 y neonatal 45,X/46,X,isoYp 5 recurrent otitis normal
£age at the moment of examination in years,
££age at the moment of diagnosis.
**more clinical data are not available.
AoAsc ascending aorta.
EMS external masculinisation score.
doi:10.1371/journal.pone.0054977.t002
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In TS, morbidity and mortality are high compared to the
general population and cardiocirculatory disease accounts for the
greatest excess mortality [4–6]. Cardiovascular disease is frequent
and consists of structural heart defect, aortic dilation, hypertension
and conductance disturbances. Congenital heart disease is
common with a prevalence of 25 to 45%. Structural defects are
mostly found at the left side of the heart with bicuspid aortic valve
and coarctation being the most common [3,7–9]. In the last 20
years, focus has been put on the dilation of the ascending aorta
which can lead to dissection, disruption and sudden death at
a relatively young age [4,5,21,24–26]. Sporadic case reports
describe coarctation and dilatation of the ascending aorta in males
with 45,X/46,XY [16], suggesting similar underlying cardiovas-
cular problems, but to our knowledge, this study is the first to
investigate ECG, cardiac morphology and heart function in males
with 45,X/46,XY as compared to 45,X/46,XY females.
The use of echocardiography in Turner patients is complicated
by the disturbed body composition and short neck, and often
yields inconclusive data [27]. In 5 of our 18 patients, visualisation
was insufficient to obtain all information. Cardiac MRI was
performed in all patients who did not require sedation to obtain
full data acquisition (12/18, including all patients with suboptimal
visualisation by echocardiography).
In our study population, bicuspid aortic valves were found in
nearly 50% of the patients, with an almost equal distribution in
males and females (3/8 F, 5/10 M), compared to 12.5% to 20%
described in the general Turner literature [3,7,9,28] and 1% in the
general population [29]. None of the valves was stenotic nor
insufficient.
Dilation of the aorta was only found at the site of the ascending
aorta and was present in 4 boys (age 3 to 10 years old); all had
a BAV. Two other boys were younger than 1 year old and had
a normal aorta on echocardiography. However, longitudinal
follow up is needed to rule out dilation in the future. In the 8
female patients, no AoAsc dilation was found.
MRI revealed the presence of a right arteria lusoria in 2/18
patients (1 F, 1 M). In the general population, the incidence of this
anatomical variant is estimated at 0.4 to 2% [30]. Although
described in the Turner population, no cases of abnormal venous
return were found in our series.
In TS, ECG abnormalities are frequently seen both in girls and
adults. Heart rates of TS patients tend to be higher compared to
normal controls and QTc prolongation is more frequent (in 20 to
30%) [31–33]. Although for all patients in our series heart rate was
within the normal limits, 6 patients (3 F, 3 M) showed a frequency
at the upper limit. QTc interval exceeded 450 ms in 5 patients
(3 F, 2 M) and QTc dispersion was abnormal in 10 (6 F, 4 M). In
TS these finding are attributed to a disturbed sympathic-
parasympathic balance [33]. The results of our study suggest that
this imbalance is also present in 45,X/46,XY mosaic boys.
In our relatively young population, in office blood pressure
measurement, as a primary screening tool, did only show mild
hypertension in 3 (2F, 1M). Follow-up studies should include 24
hour ambulatory blood to rule out hypertension or loss of
circadian rhythm.
The majority of both female and male patients included in our
study were treated with growth hormone for short stature. Growth
hormone however has not been associated with left ventricular
hypertrophy, aortic dilation or hypertension in TS [34–36].
We found structural cardiovascular pathology in 6/10 males
with 45,X/46,XY mosaicism as compared to 4/8 females. These
problems were not only found in patients with ambiguous genitalia
but to the same extent in males with apparently normal male
genital development. However, those with cardiovascular pathol-
ogy frequently showed multiple clinical features, typically associ-
ated with TS, as short neck, shield chest and short metacarpals. In
the literature, a more sever phenotype in female Turner patients is
associated with a higher prevalence of congenital heart disease and
aortic dilation [9]. Unfortunately, detailed phenotypic data were
Figure 1. Maximum Intensity Projection image of contrast
enhanced subtraction magnetic resonance angiography in
arterial phase during intraveneous injection of Meglumine
Gadoterate (DotaremH). Pulmonary artery is cut out for clarity.
Ascending aorta is dilated, normalizing over the arch; small calibre
abdominal aorta. Normal branching of supra-aortic arteries.
doi:10.1371/journal.pone.0054977.g001
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not available for all participants. Large multicenter studies might
be highly valuable to study the relation between cardiac
abnormalities and Turner stigmata in 45,X/46,XY mosaicism.
The type of cardiovascular pathology encountered in TS does
not always cause signs or symptoms. Therefore, recently, in-
ternational guidelines advise a cardiac screening by an experi-
enced cardiologist for every Turner patient at the time of
diagnosis. For those with an apparent normal cardiovascular
system and blood pressure, re-evaluation with MRI is advised at
transition and subsequently every 5 to 7 years [12]. Besides 1 boy
with an innocent murmur, none of our male patients showed
clinical signs or symptoms that warranted a cardiac screening. We
therefore recommend that the same guidelines on cardiac
screening should be applied in all individuals, males and females
alike, who are diagnosed with 45,X/46,XY mosaicism, irrespec-
tive of a normal clinical cardiac examination. Until more data are
available on the natural progression of aortic dilation, repeated
evaluation by echocardiography and MRI seems advisable.
No solid data currently exist to well-found guidelines on the
prevention and treatment of dilation in Turner patients. The way
of medical treatment, the optimal time to start and its benefits
remain largely unknown. In most centres, current management is
based on experience in Marfan patients who show similar aortic
dilation. Medical treatment is started when the AoAsc diameter
exceeds a z-score of +2. For Turner patients, Matura proposes to
use an indexed AoAsc .20 mm/BSA as a cut-off value for
abnormal dilation [21]. As a treatment, ACE inhibitors,
betablockers and angiotensin-converting enzyme are prescribed
but the usefulness of neither of them is proven. Also timing of
surgical intervention is a subject of discussion. An indexed AoAsc
$25 mm/BSA accounts for the 99th percentile in the Turner
population, is associated with a very high risk for an acute aortic
event and is currently used as an indication for surgical
intervention [21]. High blood pressure poses an additional risk,
both for dilation and atherosclerotic disease. Rigorous antihyper-
tensive treatment is recommended by the classical therapies. In
patients with prolonged QTc, medication with QTc prolonging
property should be avoided. Because of the great similarity in
cardiovascular pathology in 45,X/46,XY males and females, and
due to the lack of prospective data, it currently seems logical to
apply the same treatment strategy in these group as the one used in
typical TS. In our cohort, we subsequently started treatment with
an ACE-inhibitor in one and a beta-blocker in another boy.
Several limitations of the study should be taken into account.
The number of patients included in the study is small. Patients
were recruited via the Belgian Registry for Growth and Puberty
problems and a university DSD outpatient clinic. This could cause
a selection bias towards short boys and/or boys born with
ambiguous genitalia. The study design does not allow to define the
frequency of cardiovascular pathology in 45,X/46,XY males with
a normal male phenotype, diagnosed in adult life. Follow-up
studies should include a large sample of asymptomatic 45,X/
46,XY males, and males diagnosed with mosaicism during work-
up for infertility.
Conclusion
Males with 45,X/46,XY mosaicism have the same type and
frequency of cardiovascular pathology as 45,X/46,XY females
with an incidence similar to what is found in classic TS patients.
Dilation of the ascending aorta can occur early in life and might
become life threatening. We advise cardiac screening and life-long
monitoring in all males with 45,X/46,XY mosaicism according to
the existing guidelines for TS.
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